Victory Capital Management
JAZZ icon

Victory Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Victory Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.5M Buy
256,598
+6,920
+3% +$1.21M 0.03% 548
2025
Q4 		$42.4M Sell
249,678
-55,663
-18% -$8.53M 0.02% 609
2025
Q3 		$40.2M Sell
305,341
-51,621
-14% -$6.19M 0.02% 649
2025
Q2 		$37.9M Buy
356,962
+64,605
+22% +$7.02M 0.02% 649
2025
Q1 		$36.3M Buy
292,357
+29,668
+11% +$3.87M 0.04% 578
2024
Q4 		$32.4M Buy
262,689
+9,390
+4% +$1.11M 0.03% 648
2024
Q3 		$28.2M Buy
253,299
+47,807
+23% +$5.24M 0.03% 700
2024
Q2 		$21.9M Buy
205,492
+61,458
+43% +$6.76M 0.02% 775
2024
Q1 		$17.3M Buy
144,034
+7,445
+5% +$912K 0.02% 867
2023
Q4 		$16.8M Buy
136,589
+5,614
+4% +$701K 0.02% 842
2023
Q3 		$17M Sell
130,975
-5,811
-4% -$774K 0.02% 808
2023
Q2 		$17M Buy
136,786
+4,008
+3% +$539K 0.02% 838
2023
Q1 		$19.4M Sell
132,778
-414,181
-76% -$61.3M 0.02% 795
2022
Q4 		$87.1M Sell
546,959
-259,740
-32% -$38.1M 0.1% 261
2022
Q3 		$108M Buy
806,699
+50,153
+7% +$7.63M 0.13% 204
2022
Q2 		$118M Buy
756,546
+111,605
+17% +$17.2M 0.13% 179
2022
Q1 		$101M Sell
644,941
-169,525
-21% -$24.6M 0.1% 264
2021
Q4 		$104M Buy
814,466
+84,842
+12% +$11.2M 0.1% 273
2021
Q3 		$95M Sell
729,624
-2,083
-0.3% -$315K 0.09% 284
2021
Q2 		$130M Buy
731,707
+641,921
+715% +$111M 0.12% 193
2021
Q1 		$14.8M Buy
89,786
+1,703
+2% +$280K 0.02% 1020
2020
Q4 		$14.5M Buy
88,083
+11,373
+15% +$1.69M 0.02% 1007
2020
Q3 		$10.9M Buy
76,710
+35,516
+86% +$4.4M 0.01% 1016
2020
Q2 		$4.54M Sell
41,194
-31,150
-43% -$3.44M 0.01% 1182
2020
Q1 		$7.22M Sell
72,344
-22,992
-24% -$2.97M 0.01% 1171
2019
Q4 		$14.2M Sell
95,336
-15,585
-14% -$2.12M 0.02% 918
2019
Q3 		$14.2M Buy
110,921
+6,251
+6% +$838K 0.02% 902
2019
Q2 		$14.9M Buy
104,670
+86,606
+479% +$11.6M 0.03% 692
2019
Q1 		$2.58M Sell
18,064
-4,512
-20% -$589K 0.01% 1031
2018
Q4 		$2.8M Sell
22,576
-179,424
-89% -$26.6M 0.01% 955
2018
Q3 		$34M Buy
202,000
+191,870
+1,894% +$33M 0.07% 468
2018
Q2 		$1.75M Sell
10,130
-530
-5% -$86.6K ﹤0.01% 1105
2018
Q1 		$1.61M Sell
10,660
-188
-2% -$27.6K ﹤0.01% 1128
2017
Q4 		$1.46M Buy
10,848
+1,380
+15% +$191K ﹤0.01% 1134
2017
Q3 		$1.39M Buy
9,468
+6,058
+178% +$916K ﹤0.01% 1126
2017
Q2 		$530K Buy
3,410
+132
+4% +$20.2K ﹤0.01% 1302
2017
Q1 		$476K Buy
3,278
+2,999
+1,075% +$391K ﹤0.01% 1317
2016
Q4 		$30K Sell
279
-303,165
-100% -$33.8M ﹤0.01% 1740
2016
Q3 		$36.9M Buy
303,444
+302,589
+35,391% +$40.8M 0.1% 336
2016
Q2 		$121K Buy
855
+513
+150% +$75.6K ﹤0.01% 1228
2016
Q1 		$45K Sell
342
-496
-59% -$61.7K ﹤0.01% 1432
2015
Q4 		$118K Sell
838
-356
-30% -$49.3K ﹤0.01% 1254
2015
Q3 		$159K Buy
+1,194
New +$206K ﹤0.01% 1145
2015
Q2 		– Sell
-42,335
Closed -$7.32M – 1632
2015
Q1 		$7.32M Buy
42,335
+18,180
+75% +$3.12M 0.03% 505
2014
Q4 		$3.96M Buy
+24,155
New +$4.01M 0.01% 574

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Victory Capital Management's JAZZ Position: Q1 2026 in Review

Victory Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 2.8% in Q1 2026, buying an estimated $1.21M and bringing the position to 256,598 shares worth $48.5M. The position accounts for 0.03% of the portfolio, ranked #548.

Victory Capital Management first reported a position in JAZZ in Q4 2014 and has held it in 45 quarters since. The position peaked at $130M in Q2 2021. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Victory Capital Management held 256,598 shares of Jazz Pharmaceuticals worth $48.5M as of Q1 2026.
  • Victory Capital Management bought 6,920 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.21M.
  • Jazz Pharmaceuticals made up 0.03% of Victory Capital Management's portfolio in Q1 2026, its #548 holding.
  • Victory Capital Management first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 45 quarters since.
  • Victory Capital Management's Jazz Pharmaceuticals position peaked at $130M in Q2 2021.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.